Clinical Trial Update: Feasibility Trial of a Stakeholder-enhanced Lay-navigator-delivered Intervention (ImPart-Multi) [NA]

View source ↗

Summary

Completed feasibility trial of a stakeholder-enhanced lay-navigator-delivered intervention (ImPart-Multi) for kidney diseases; results were posted on 2026-02-13…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Chronic Kidney Disease

Snippet

Sponsor: University of Alabama at Birmingham | Conditions: Kidney Diseases, Cardiometabolic Risk Factors | NA | Status: COMPLETED | Results posted: 2026-02-13